Industry Growth Insights published a new data on “Novel Coronavirus (COVID-19) Vaccine Market”. The research report is titled “Novel Coronavirus (COVID-19) Vaccine Market research by Types (DNA, RNA, Others), By Applications (Mild Symptom Patient, Critically Ill Patient), By Players/Companies Inovio Pharmaceuticals, Takis Biotech (Evvivax), Zydus Cadila, Codagenix, Inc., GeoVax, Inc., Bravovax, Janssen Pharmaceutical Companies, Altimmune, Vaxart, CanSino Biologics, ExpreS2ion Biotechnologies ApS, Clover Biopharmaceuticals, GSK, Vaxil Bio Ltd., Generex, Novavax, Inc., Sanofi Pasteur, Baylor, iBio, Inc., Moderna, Inc., Curevac, ImmunoPrecise”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Novel Coronavirus (COVID-19) Vaccine Market Research Report
By Type
DNA, RNA, Others
By Application
Mild Symptom Patient, Critically Ill Patient
By Companies
Inovio Pharmaceuticals, Takis Biotech (Evvivax), Zydus Cadila, Codagenix, Inc., GeoVax, Inc., Bravovax, Janssen Pharmaceutical Companies, Altimmune, Vaxart, CanSino Biologics, ExpreS2ion Biotechnologies ApS, Clover Biopharmaceuticals, GSK, Vaxil Bio Ltd., Generex, Novavax, Inc., Sanofi Pasteur, Baylor, iBio, Inc., Moderna, Inc., Curevac, ImmunoPrecise
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
 Vaccine Industry Outlook.svg)
Global Novel Coronavirus (COVID-19) Vaccine Market Report Segments:
The global Novel Coronavirus (COVID-19) Vaccine market is segmented on the basis of:
Types
DNA, RNA, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Mild Symptom Patient, Critically Ill Patient
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Inovio Pharmaceuticals
- Takis Biotech (Evvivax)
- Zydus Cadila
- Codagenix, Inc.
- GeoVax, Inc.
- Bravovax
- Janssen Pharmaceutical Companies
- Altimmune
- Vaxart
- CanSino Biologics
- ExpreS2ion Biotechnologies ApS
- Clover Biopharmaceuticals
- GSK
- Vaxil Bio Ltd.
- Generex
- Novavax, Inc.
- Sanofi Pasteur
- Baylor
- iBio, Inc.
- Moderna, Inc.
- Curevac
- ImmunoPrecise
 Vaccine Market Overview.svg)
Highlights of The Novel Coronavirus (COVID-19) Vaccine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- DNA
- RNA
- Others
- By Application:
- Mild Symptom Patient
- Critically Ill Patient
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Novel Coronavirus (COVID-19) Vaccine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Vaccine Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The COVID-19 vaccine is a new type of vaccine that helps protect people from the coronavirus. The vaccine was developed by scientists in collaboration with the World Health Organization (WHO). It is currently being tested in humans and could become available for use as early as 2020.nnThe COVID-19 vaccine works by helping to prevent people from getting sick with the coronavirus. It does this by protecting them against infection with the virus itself, as well as against any symptoms that may occur after they are infected. The WHO has said that there is a good chance that this new type of coronavirus vaccine will be more effective than other types currently available on the market.
Some of the major companies in the novel coronavirus (covid-19) vaccine market are Inovio Pharmaceuticals, Takis Biotech (Evvivax), Zydus Cadila, Codagenix, Inc., GeoVax, Inc., Bravovax, Janssen Pharmaceutical Companies, Altimmune, Vaxart, CanSino Biologics, ExpreS2ion Biotechnologies ApS, Clover Biopharmaceuticals, GSK, Vaxil Bio Ltd., Generex, Novavax, Inc., Sanofi Pasteur, Baylor, iBio, Inc., Moderna, Inc., Curevac, ImmunoPrecise.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Novel Coronavirus (COVID-19) Vaccine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Novel Coronavirus (COVID-19) Vaccine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Novel Coronavirus (COVID-19) Vaccine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Novel Coronavirus (COVID-19) Vaccine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Novel Coronavirus (COVID-19) Vaccine Market Size & Forecast, 2018-2028
4.5.1 Novel Coronavirus (COVID-19) Vaccine Market Size and Y-o-Y Growth
4.5.2 Novel Coronavirus (COVID-19) Vaccine Market Absolute $ Opportunity
Chapter 5 Global Novel Coronavirus (COVID-19) Vaccine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Novel Coronavirus (COVID-19) Vaccine Market Size Forecast by Type
5.2.1 DNA
5.2.2 RNA
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Novel Coronavirus (COVID-19) Vaccine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Novel Coronavirus (COVID-19) Vaccine Market Size Forecast by Applications
6.2.1 Mild Symptom Patient
6.2.2 Critically Ill Patient
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Novel Coronavirus (COVID-19) Vaccine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Novel Coronavirus (COVID-19) Vaccine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Novel Coronavirus (COVID-19) Vaccine Analysis and Forecast
9.1 Introduction
9.2 North America Novel Coronavirus (COVID-19) Vaccine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Novel Coronavirus (COVID-19) Vaccine Market Size Forecast by Type
9.6.1 DNA
9.6.2 RNA
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Novel Coronavirus (COVID-19) Vaccine Market Size Forecast by Applications
9.10.1 Mild Symptom Patient
9.10.2 Critically Ill Patient
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Novel Coronavirus (COVID-19) Vaccine Analysis and Forecast
10.1 Introduction
10.2 Europe Novel Coronavirus (COVID-19) Vaccine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Novel Coronavirus (COVID-19) Vaccine Market Size Forecast by Type
10.6.1 DNA
10.6.2 RNA
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Novel Coronavirus (COVID-19) Vaccine Market Size Forecast by Applications
10.10.1 Mild Symptom Patient
10.10.2 Critically Ill Patient
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Novel Coronavirus (COVID-19) Vaccine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Novel Coronavirus (COVID-19) Vaccine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Novel Coronavirus (COVID-19) Vaccine Market Size Forecast by Type
11.6.1 DNA
11.6.2 RNA
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Novel Coronavirus (COVID-19) Vaccine Market Size Forecast by Applications
11.10.1 Mild Symptom Patient
11.10.2 Critically Ill Patient
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Novel Coronavirus (COVID-19) Vaccine Analysis and Forecast
12.1 Introduction
12.2 Latin America Novel Coronavirus (COVID-19) Vaccine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Novel Coronavirus (COVID-19) Vaccine Market Size Forecast by Type
12.6.1 DNA
12.6.2 RNA
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Novel Coronavirus (COVID-19) Vaccine Market Size Forecast by Applications
12.10.1 Mild Symptom Patient
12.10.2 Critically Ill Patient
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Novel Coronavirus (COVID-19) Vaccine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Novel Coronavirus (COVID-19) Vaccine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Novel Coronavirus (COVID-19) Vaccine Market Size Forecast by Type
13.6.1 DNA
13.6.2 RNA
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Novel Coronavirus (COVID-19) Vaccine Market Size Forecast by Applications
13.10.1 Mild Symptom Patient
13.10.2 Critically Ill Patient
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Novel Coronavirus (COVID-19) Vaccine Market: Competitive Dashboard
14.2 Global Novel Coronavirus (COVID-19) Vaccine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Inovio Pharmaceuticals
14.3.2 Takis Biotech (Evvivax)
14.3.3 Zydus Cadila
14.3.4 Codagenix, Inc.
14.3.5 GeoVax, Inc.
14.3.6 Bravovax
14.3.7 Janssen Pharmaceutical Companies
14.3.8 Altimmune
14.3.9 Vaxart
14.3.10 CanSino Biologics
14.3.11 ExpreS2ion Biotechnologies ApS
14.3.12 Clover Biopharmaceuticals
14.3.13 GSK
14.3.14 Vaxil Bio Ltd.
14.3.15 Generex
14.3.16 Novavax, Inc.
14.3.17 Sanofi Pasteur
14.3.18 Baylor
14.3.19 iBio, Inc.
14.3.20 Moderna, Inc.
14.3.21 Curevac
14.3.22 ImmunoPrecise
